Clinical trial
A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired…
NCT00042588 · ICOS Corporation, Industry · Completed
Key facts
| NCT number | NCT00042588 |
|---|---|
| Title | A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis |
| Official title | A Phase 2 Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis |
| Lead sponsor | ICOS Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pneumonia, Sepsis |
| Intervention type | Drug |
| Interventions | Recombinant Chimeric Monoclonal Antibody |
| Start date | May 1, 2002 |
| First posted | Aug 5, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: